Stock ZBH ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
119.4 USD -0.33% Intraday chart for Zimmer Biomet Holdings, Inc. -1.18% -1.93%
Apr. 15 Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept MT
Apr. 04 Zimmer Biomet Partners with Three Pickleball Organizations in US MT

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's high margin levels account for strong profits.

Weaknesses

  • With a 2024 P/E ratio at 22.89 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • With an enterprise value anticipated at 3.68 times the sales for the current fiscal year, the company turns out to be overvalued.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.93% 24.6B
B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 185B
C+
MEDTRONIC PLC Stock Medtronic plc
-3.20% 105B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.59B
A
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 54.66B
B-
CENCORA, INC. Stock Cencora, Inc.
+17.29% 47.78B
B-
HOYA CORPORATION Stock Hoya Corporation
+4.06% 41.26B
B+
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.95B
A-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.37B
B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.8B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. Ratings Zimmer Biomet Holdings, Inc.